Tulasikumari Kanipakala

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

Integrated BioTherapeutics (United States)(Current)

Tulasikumari Kanipakala is an author at Integrated BioTherapeutics (United States) specializing in infectious diseases, veterinary medicine, and pore-forming toxins.

Publications per year

2015–2022

Publications

Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs

Rajan P. Adhikari, Thomas Kort, Sergey Shulenin et al. · PLoS ONE · 2015 · 34 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Critical Role for HlgA in Staphylococcus aureus Pathogenesis Revealed by A Switch in the SaeRS Two-Component Regulatory System

Arundhathi Venkatasubramaniam, Tulasikumari Kanipakala, Nader Ganjbaksh et al. · Toxins · 2018 · 29 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB)

Shweta Kailasan, Thomas Kort, Ipsita Mukherjee et al. · Toxins · 2019 · 18 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Antigenic landscapes on <i>Staphylococcus aureus</i> pore-forming toxins reveal insights into specificity and cross-neutralization

Shweta Kailasan, Ravi Kant, Madeleine Noonan-Shueh et al. · mAbs · 2022 · 11 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–4 of 4